Vaccine: multipeptide cocktail suits patients

August 1, 2004

New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.